Bayer CropScience Limited has announced its financial results for the third quarter of FY25, reporting a 10.7% year-on-year (YoY) increase in revenue but a significant 63.3% YoY decline in net profit due to higher expenses and lower margins.
Key Financial Highlights (Standalone)
- Q3 Revenue: ₹1,056.9 crore, up 10.7% YoY from ₹954.9 crore in Q3 FY24.
- Nine-Month Revenue: ₹4,425.7 crore, up 2.6% YoY from ₹4,311.7 crore.
- Net Profit for Q3: ₹34.2 crore, down 63.3% YoY from ₹93.1 crore.
- Nine-Month Net Profit: ₹424.7 crore, down 34.1% YoY from ₹644.5 crore.
- Earnings Per Share (EPS): ₹7.61 for Q3 FY25, compared to ₹20.72 in Q3 FY24.
Key Expenses & Profitability Trends
- Cost of Materials Consumed: ₹691.3 crore in Q3 FY25, significantly higher than ₹363.9 crore in Q3 FY24, impacting profitability.
- Total Expenses: ₹1,056.0 crore, up 24.9% YoY, driven by increased raw material costs and employee expenses.
- Profit Before Tax (PBT): ₹33.6 crore, down 73.0% YoY from ₹124.2 crore.
-
CFO & Director Changes:
- Mr. Simon Johannes Britsch (Whole-Time Director & CFO) resigned, effective 28th February 2025, due to repatriation to Bayer AG.
- Dr. Miriam Holstein (Non-Executive Director) also resigned, effective 28th February 2025.
- Mr. Vinit Rajesh Jindal appointed as Whole-Time Director & CFO from 1st March 2025.
- Ms. Jana Marlen Ackermann appointed as Non-Executive Director from 1st March 2025.
-
Senior Management Change:
- Ms. Priya D’Cruz designated as Senior Management Personnel (SMP) from 12th February 2025.
Bayer CropScience remains focused on supply chain efficiency, cost management, and expansion of its agribusiness portfolio. Despite a challenging quarter, the company is optimistic about revenue stability and long-term growth prospects in India’s agricultural sector.
TOPICS:
Bayer CropScience